IPP Bureau
Doctors at MGM Healthcare perform complex bilateral lung transplant
By IPP Bureau - August 26, 2021
The boy becomes India’s youngest recipient to undergo bilateral lung transplantation.
Adjuvance announce clinical results of its next-gen saponin adjuvant
By IPP Bureau - August 26, 2021
First results demonstrate favourable tolerability of TQL-1055 at all dose levels
Wockhardt and Jemincare partner for novel respiratory antibiotic Nafithromycin
By IPP Bureau - August 26, 2021
The company to receive upfront and milestone payments, in addition to royalties
Merck donates Rs 1.7 crore to IIT Bombay for Covid-19 research
By IPP Bureau - August 26, 2021
The two-year donation supports the development of clinical tests for Covid-19 severity assessment and the focus on the development of simple immunoassays using single molecule counting technology
Sai Life Sciences is now a United Nations Global Compact (UNGC) signatory
By IPP Bureau - August 26, 2021
In the last two years, Sai Life Sciences has made significant investments and progress in advancing its sustainability agenda as part of its organizational transformation initiative
RedHill Biopharma's Opaganib demonstrates strong inhibition of COVID-19 Delta variant
By IPP Bureau - August 26, 2021
Opaganib, a leading novel small molecule investigational oral pill in development for Covid-19, is a unique host targeted, dual antiviral and anti-inflammatory drug that acts on the cause and effect of the disease
Strong show in domestic formulations business by Indian pharma in Q1FY22: Ind-Ra
By IPP Bureau - August 26, 2021
Domestic business was up 41.9% YoY and 27.7% QoQ
Pune-based Jehangir Hospital records 500 kidney transplants
By IPP Bureau - August 25, 2021
The hospital works in close collaboration with the Network for Organ Sharing and the National Organ & Tissue Transplant Organisation (NOTTO) and it is amongst the very few hospitals doing ABO-incompatible transplant
US FDA approves Medtronic’s TAVR System
By IPP Bureau - August 25, 2021
The Evolut FX TAVR system is used for treatment of symptomatic severe aortic stenosis and it has features that enhance ease-of-use and predictable valve deployment
Regimen launches world’s first personalised digital therapy for ED
By IPP Bureau - August 25, 2021
The company recently raised US $ 2.25 million seed round and the app was CE-Certified as a medical device in Europe
Lonza to establish manufacturing facility in Guangzhou, China
By IPP Bureau - August 25, 2021
The investment will establish drug product manufacturing capacity for clinical trial and commercial supply in China and offer customers combined drug substance and drug product manufacturing services
Medtronic partners with ASAP, Kerala for Internship
By IPP Bureau - August 25, 2021
Goal of providing 12-month internship opportunities for qualified students
Cipla forms JV with Kemwell Biopharma
By IPP Bureau - August 25, 2021
The agreement is to develop, manufacture and commercialise biosimilars for the global market.
CRISIL positive on Krishna Institute of Medical Sciences
By IPP Bureau - August 25, 2021
CRISIL Ratings has revised its outlook on the long term ratings of Krishna Institute Of Medical Sciences Limited (KIMS) to 'Positive' from 'Stable' while reaffirming the ratings at 'CRISIL AA-/CRISIL A1+'
Carbogen Amcis AG signs co-investment agreement
By IPP Bureau - August 25, 2021
The co-investment of CHF 4 million will result in capacity expansion and support the market introduction of the customer's lead compound
